Page 4 - Pharma Sector News Today

Despite an over 86 percent gain in the stock in 2023 YTD, domestic brokerage house Investec sees pharma firm Orchid Pharma (ORCD) rising another 23 percent in the next 12 months. The brokerage has initiated coverage on the stock with a ‘buy’ call and a target price of ₹800.

The Pakistan Pharmaceutical Manufacturers’ Association (PPMA) has on Monday lamented the government’s apathy towards...

B&K Securities airs concerns considering Cipla’s significant exposure to the US market, constituting 28% of consolidated sales

Investment banking firm expects pharma major’s revenue to reach Rs 10,164.6 crore by FY26

LAHORE: The Pakistan pharmaceutical industry has the potential to fetch precious foreign exchange through exports of...

“If cricket franchises were to list, we would have to understand the business models. Are they profitable? Sports franchises listed elsewhere often burn a lot of cash. It is an interesting sector, but one would probably need to understand the financials a bit better before being able to confirm whether to look at them.”

Company says there’s no significant risk to its existing commercial product portfolio

Over 37 million individuals grapple with COPD in India, it is among the leading causes of death in the nation

Executive Director Pharma Bureau Ayesha Tammy Haque has advised the government to do away with price regulation,...

KARACHI: Conducive policies, fair pricing mechanisms, and investment in research and development are crucial for the...